ISPOR 2026 Home
  • About
    • News Center
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Exhibits & Sponsorship
    • Exhibitor Directory
    • Sponsors
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Past Conferences
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • COST-EFFECTIVENESS ANALYSIS OF AI ROBOTIC-ASSISTED RADICAL PROSTATECTOMY

    Mar 18, 2026, 21:38 PM
  • DISPROPORTIONALITY ANALYSIS AND MULTIMODAL GENETIC ASSESSMENT OF PAPILLEDEMA ASSOCIATED WITH PROTEASOME INHIBITORS

    Mar 18, 2026, 21:38 PM
  • UPTAKE OF THE RSVPREF VACCINE DURING PREGNANCY: ASSOCIATIONS WITH SOCIOECONOMIC STATUS, PRENATAL CARE UTILIZATION, AND MATERNAL RISK FACTORS

    Mar 18, 2026, 21:38 PM
  • UNDERSTANDING PRIORITIES IN HEALTH ECONOMICS: MAPPING COST-EFFECTIVENESS AND DISEASE BURDEN TRENDS

    Mar 18, 2026, 21:38 PM
  • IDENTIFYING MEANINGFUL PATIENT SAVINGS ON GENERICS: DIRECT-TO-CONSUMER PRICES VS COMMERCIAL INSURANCE

    Mar 18, 2026, 21:38 PM
  • CATASTROPHIC HEALTH EXPENDITURE SUBSTANTIALLY UNDERESTIMATES FINANCIAL HARDSHIP IN HOUSEHOLDS WITH CHRONIC CONDITIONS

    Mar 18, 2026, 21:38 PM
  • HEALTH-RELATED QUALITY OF LIFE AND EMOTION REGULATION STRATEGIES IN ADOLESCENTS WITH DEPRESSION IN CHINA: A CROSS-SECTIONAL STUDY

    Mar 18, 2026, 21:38 PM
  • VALIDATION OF AN AGENTIC LARGE LANGUAGE MODEL (LLM) SYSTEM IN THE EXTRACTION STAGE OF A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR): A SOLUTION TO INSTANT AND EASY ACCESS TO CLINICAL TRIAL DATA (CTD)

    Mar 18, 2026, 21:38 PM
  • STRATEGIC MARKET ACCESS PLANNING IN BREAST AND LUNG CANCER ENABLED BYREAL-TIMEAI-ASSISTEDLIVINGSYSTEMATICLITERATUREREVIEW (REAL-SLR)SYSTEM

    Mar 18, 2026, 21:38 PM
  • POST-2020 REAL-WORLD EVIDENCE ON PHARMACOTHERAPIES FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A SCOPING REVIEW

    Mar 18, 2026, 21:38 PM
  • HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS

    Mar 18, 2026, 21:38 PM
  • ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM

    Mar 18, 2026, 21:38 PM
  • ASSESSING SOCIAL MEDIA SENTIMENT TO ANALYZE PATIENT, CAREGIVER AND HEALTHCARE PROFESSIONALS EXPERIENCE WITH IMMUNOGLOBULIN (IVIG AND SCIG) FOR CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY (CIDP)

    Mar 18, 2026, 21:38 PM
  • DIRECT ORAL ANTICOAGULANTS IN BRAZIL: PRICE TRENDS, MARKET COMPETITION, AND POLICY IMPLICATIONS

    Mar 18, 2026, 21:38 PM
  • LABORATORY-BASED MACHINE LEARNING ALGORITHM REDUCES UNCERTAINTY AND ENHANCES DIAGNOSTIC ACCURACY IN PERIPROSTHETIC JOINT INFECTION

    Mar 18, 2026, 21:38 PM
  • PREVALENCE RATES OF MYOTONIC DYSTROPHY TYPE 1 (DM1) IN 9 COUNTRIES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

    Mar 18, 2026, 21:38 PM
  • ADHERENCE TO MULTI-TARGET STOOL DNA TESTING FOR COLORECTAL CANCER SCREENING IN A NORTHEASTERN U.S. CORRECTIONAL FACILITY

    Mar 18, 2026, 21:38 PM
  • ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING SLEEVE GASTRECTOMY: A RETROSPECTIVE DATABASE ANALYSIS

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY

    Mar 18, 2026, 21:38 PM
  • INCLUSION OF PATIENT-REPORTED OUTCOME MEASURES FOR PEDIATRIC VERSUS ADULT POPULATIONS IN FDA BIOLOGICAL AND NOVEL DRUG THERAPY APPROVALS FROM 2021-2025

    Mar 18, 2026, 21:38 PM
  • 1
  • 2
  • 3
  • 4 (current)
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group